Cervical Radiculopathy
Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.
Patient Summary
- Is this FDA-cleared for this use?
- No — investigated off-label. The FDA cleared medicinal leeches in 2004 only for venous congestion in microsurgical reconstruction (K040187). Use for cervical radiculopathy is investigational, with no verifiable published trial, and is not FDA-evaluated.
- What evidence exists?
- No verifiable published trial of leech therapy for cervical radiculopathy exists. A previously cited randomized trial could not be verified for this indication, and its citation was removed. The proposed rationale is extrapolated from leech studies in other musculoskeletal pain conditions and remains speculative. Leech therapy is not appropriate when there is progressive weakness, severe nerve compression on imaging, or any sign of spinal cord involvement — those require urgent surgical evaluation.
- Main risks
- Bleeding and oozing from bite sites on the neck and shoulder for several hours
- Bruising along the neck for 3 to 7 days, which can be cosmetically noticeable
- Itching, redness, and irritation at bite sites for days to weeks
- Small permanent scars on the neck or upper back
- Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of pain or stiffness for 1 to 2 days after the session
- Who should not consider this
- Patients taking blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
- Patients with hemophilia or other inherited bleeding disorders
- Patients with severe anemia (hemoglobin under 10 g/dL)
- Patients with a weakened immune system
- Patients with progressive arm weakness, hand clumsiness, or balance problems (surgical evaluation needed)
- Patients with spinal cord compression on imaging (urgent surgical evaluation)
- Patients with any sign of infection near the spine
- What to ask your clinician
- Have I had an MRI, and is there a structural problem that needs surgical evaluation first?
- Am I a candidate for standard treatments — physical therapy, NSAIDs, epidural steroid injection — and have I given them a fair trial?
- What is the realistic chance leech therapy will help me, and for how long?
- What is the practitioner's experience with cervical-region leech application?
- What antibiotic plan do you use for Aeromonas prevention?
- What red flags should I and my family watch for after the session?
- What is the cost, and is it covered by insurance? (typically not)
- When to seek urgent care
- New or worsening weakness in the arm or hand
- New numbness, tingling, or weakness in the legs, balance problems, or loss of bladder/bowel control (possible spinal cord involvement — emergency)
- Sudden severe neck pain with fever and stiff neck (possible spinal infection)
- Bleeding from a bite site lasting more than 24 hours
- Spreading redness, warmth, pus, or red streaks (cellulitis)
- Fever above 38.0 C / 100.4 F or chills
- Hives, throat tightness, or breathing difficulty
What this does NOT mean
- It does not mean leech therapy is FDA-approved for cervical radiculopathy — it is not.
- It does not mean leech therapy fixes the underlying disc or bone problem — it may only reduce symptoms temporarily.
- It does not mean it replaces neurosurgical evaluation when there are red-flag features such as progressive weakness or spinal cord signs.
- It does not mean every patient improves — with no verifiable published trial for this indication, individual responses cannot be predicted.
- It does not mean improvement is permanent — long-term outcomes have not been studied for this indication.
Safety cross-references
Clinical Profile
- Category
- Neurological
- ICD-10
- M50.10, M50.11, M50.12, M50.13, M54.12
- Safety tier
- Medium
Evidence Summary
No randomized controlled trial or clinical study of leech therapy for cervical radiculopathy has been published. A proposed rationale, extrapolated from leech trials in other musculoskeletal pain syndromes, combines local anti-inflammatory effects with reduction of paravertebral venous congestion that may contribute to nerve-root edema, but this remains speculative. Use is investigational and is not a substitute for surgical evaluation in patients with progressive motor deficit.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Progressive motor deficit (surgical referral)
- Spinal cord compression on imaging
- Active epidural infection
Related Conditions
Lumbar Radiculopathy (Sciatica)
Investigational use for lumbar radiculopathy; the closest randomized evidence is in chronic low back pain (Hohmann 2018, n=44), not radicular pain.
Migraine
Investigational use with case-series evidence for reduction of migraine frequency and intensity; mechanism plausible via reduction of cervico-cranial venous congestion.
Tension-Type Headache
Investigational use for chronic tension headache; no verifiable published clinical evidence — proposed mechanism via reduction of pericranial muscle tension and venous congestion.
Sciatica (Non-Discogenic / Piriformis)
Investigational use for non-discogenic sciatica including piriformis syndrome; case-series evidence for pain reduction.